William P. Scully
Known title: 10% OwnerCIK: 0001045463
William P. Scully's purchase track record
How the stock did after each of William P. Scully's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 12 since December 18, 2024
Stock higher 6 months later
0%
3 months: 50%
Median 6-month return
-51.9%
3 months: +0.3%
Beat the S&P 500
0%
median -57.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/7/2026 | PRTA | $1.82M | pending | pending | — |
| 9/28/2026 | PRTA | $3.15M | pending | pending | — |
| 9/18/2026 | PRTA | $843K | pending | pending | — |
| 9/2/2026 | PRTA | $256K | pending | pending | — |
| 8/20/2026 | PRTA | $439K | pending | pending | — |
| 6/11/2026 | PRTA | $1.18M | +9.2% | pending | — |
| 6/2/2026 | PRTA | $937K | +4.6% | pending | — |
| 5/22/2026 | PRTA | $981K | -4.0% | pending | — |
| 1/14/2025 | PRTA | $1.28M | -24.3% | -50.9% | +6.9% |
| 12/31/2024 | PRTA | $416K | -15.2% | -54.8% | +5.4% |
| 12/18/2024 | PRTA | $1.05M | +7.8% | -51.9% | +1.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PRTA | ▲ Buy | Open Market | 90,000 | $771K | 10/8/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 125,000 | $1.1M | 10/7/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 100,000 | $857K | 10/2/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 162,000 | $1.4M | 9/29/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 103,500 | $890K | 9/28/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 100,000 | $843K | 9/18/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 27,000 | $256K | 9/2/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 50,000 | $439K | 8/20/2026 | View on chart |
| PRTA | ▼ Sell | Gift | 627,553 | $0 | 8/18/2026 | View on chart |
| PRTA | ▼ Sell | Gift | 336,000 | $0 | 8/17/2026 | View on chart |
| PRTA | ▼ Sell | Gift | 251,553 | $0 | 8/10/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 34,000 | $293K | 8/7/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 3,500 | $30K | 8/7/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 20,000 | $158K | 6/16/2026 | View on chart |
| PRTA | ▼ Sell | Gift | 325,000 | $0 | 6/15/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 125,000 | $1.0M | 6/11/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 50,000 | $465K | 6/4/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 50,000 | $471K | 6/2/2026 | View on chart |
| PRTA | ▲ Buy | Open Market | 100,000 | $981K | 5/22/2026 | View on chart |
| PRTA | ▼ Sell | Gift | 12,000 | $0 | 1/15/2025 | View on chart |
| PRTA | ▲ Buy | Open Market | 100,000 | $1.3M | 1/14/2025 | View on chart |
| PRTA | ▼ Sell | Gift | 1,000 | $0 | 1/3/2025 | View on chart |
| PRTA | ▼ Sell | Gift | 13,200 | $0 | 1/2/2025 | View on chart |
| PRTA | ▲ Buy | Open Market | 1,200 | $16K | 12/31/2024 | View on chart |
| PRTA | ▲ Buy | Open Market | 800 | $11K | 12/31/2024 | View on chart |
| PRTA | ▲ Buy | Open Market | 30,000 | $390K | 12/31/2024 | View on chart |
| PRTA | ▲ Buy | Open Market | 2,000 | $32K | 12/20/2024 | View on chart |
| PRTA | ▼ Sell | Gift | 500 | $0 | 12/20/2024 | View on chart |
| PRTA | ▼ Sell | Gift | 40,000 | $0 | 12/20/2024 | View on chart |
| PRTA | ▼ Sell | Gift | 681,000 | $0 | 12/19/2024 | View on chart |
| PRTA | ▲ Buy | Open Market | 73,436 | $1.0M | 12/18/2024 | View on chart |
| PRTA | ▼ Sell | Gift | 430,000 | $0 | 12/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Prothena included in Alzheimer's Day stock watchlist
Prothena was featured in a Yahoo Finance article listing four Alzheimer's drug stocks to watch on World Alzheimer's Day. This inclusion highlights the company's relevance in the neurodegenerative disease sector. The stock is currently trading near its 52-week low, with technical indicators showing a rejection at support levels.
Prothena included in Alzheimer's Day stock watchlist. Prothena was featured in a Yahoo Finance article listing four Alzheimer's drug stocks to watch on World Alzheimer's Day. This inclusion highlights the company's relevance in the neurodegenerative disease sector. The stock is currently trading near its 52-week low, with technical indicators showing a rejection at support levels.